Cardiogenic Shock clinical trials
19 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Pulmonary Artery Catheter in Cardiogenic Shock Trial
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
- CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- Cardiac Power Output in Cardiogenic Shock Patients
- Physiology of Unloading VA ECMO Trial
- Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- COMPARE-VENT Feasibility Pilot Study
- Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
- Intra-aortic Balloon Counterpulsation (IABC) Compliance
- Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
- Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
- Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
- Cardiogenic Shock Working Group Registry
- Inova Cardiogenic Shock Registry (INOVA SHOCK)
- CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO
- Augmented Pacing for Shock in the Cardiac Intensive Care Unit
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cardiogenic Shock” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.